SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether RxSight, Inc. (NASDAQ: RXST), or any of its executive officers, violated federal securities laws by making false or misleading statements or failing to disclose material information to investors. What if I purchased RXST securities?If you purchased RxSight securities and suffered losses on your investment, you may be eligible to participate in our investigation. To join, please click here: ...